Release Date: 10/02/17 13:57 Summary: 1300SMILES continues strategic growth Price Sensitive: Yes Download Document 624.53KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%